Cancer Drug Market Emerging Trends & Future Outlook Research Report

Cancer Drug Market is valued around USD 112.34 Billion in 2019 and expected to reach USD 246.37 Billion by 2030 with the CAGR of 7.4% over the forecast period.   
Cancer drugs are used for the treatment of abnormal growth of cells in human body. Cancer can affect any part or organ of the body and choice of drug depends on the progression of disease. Chemotherapy is one of the highly used treatment options but due to numerous side effects there is a shift observed towards targeted therapy. Rising development & use of biologics may further change the preference along with growing use of personalized medicine.
Global Cancer Drug Market report is segmented on the basis of drug class, indication and by regional. Based upon drug class, the cancer drug market is fragmented into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), and Hormonal Therapy. On the basis of indication, the market is categorized into Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer, and Other. The regional bifurcation of countries includes North America, Europe, Asia-Pacific, and RoW which are further segmented into major countries such as U.S., UK, France, and others.

The cancer drugs market is mainly driven by the high prevalence rate of cancer along with the modernizing healthcare facilities. There has been surge in technological advancement as well research & development activities for the development of effective treatment options. In addition, rising collaborations between market players followed by growing investments in the market for the development of cancer drugs are also likely to fuel the market growth. On the other hand, growing awareness among people together with rising disposable income as well as healthcare expenditure in the near future contribute the market growth. Moreover, unhealthy lifestyle, changing food habits followed by the high consumption rate of alcohol & smoking can led to cancer and in turn drive the market growth. However, high cost of cancer drugs followed by various side effects associated with cancer drugs may inhibit the market growth.

Download sample copy of this report at https://www.nextmsc.com/cancer-drug-market/request-sample

The developed regions such as North America and Europe are expected to hold the major market share owing to the presence technological advancement along with developed healthcare facilities. Moreover, presence of major market players in the region along with increase in research & development activities is likely to add up the market growth. Asia Pacific is expected to dominate the cancer drug market in terms of growth rate owing to the high prevalence rate of cancer along with the rising accessibility to healthcare services. In addition, growing disposable income along with rising awareness as well as growing investments in market are anticipated the market growth.

The major market players profiled in the cancer drug market includes Astellas Pharma Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, f. Hoffmann-La Roche ltd., Celgene Corporation, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC,), Pfizer Inc., and Novartis AG among others.


About Us:

Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
Contact US:
Joseph Lawrence (Head - Client Engagement & Servicing)
Joseph@nextmsc.com

Comments

Post a Comment

Popular posts from this blog

Donor Eggs IVF Services Market by Latest Clinical Advanced Treatment Outlook - 2030

Image
The  Global Donor Eggs IVF Services Market  size valued to USD 1.95 billion in 2019, is predicted an elevation of USD 4.83 billion by 2030, witnessing a CAGR of 8.6% from 2020-2030. Donor Eggs IVF Services Market 2020 Research Report gives the Professional and inside and out assessment of extent of momentum and future market and survey of Product Specification, showcase pattern, item type and creation investigation considering central point, for example, Facts and figure, income created from the offers of this Report, piece of the overall industry and development rate for each kind and application, Gross Margin, key variables heading to the market. And furthermore gives the inside and out assessment of Donor Eggs IVF Services Market utilizing Porter's five powers, SWOT investigation for example Quality, Weakness, Opportunities and Threat to the business. Access Full Description of this report at: - https://www.nextmsc.com/report/donor-eggs-...
Read more

Surgical Robotics Market Global Demand, Latest Technology and Outlook 2020 to 2030

Image
The Global Surgical Robotics Market size was valued at USD 66.02 billion in 2019 and is predicted to reach USD 158.70 billion by 2030 with a CAGR of 8.3% from 2020-2030. Surgical Robotics lead to minimally invasive procedures with high precision, minimal incision, reduced blood loss, lesser pain, and quicker healing time, as compared to traditional surgical procedures. In robotically assisted surgeries, the surgeon controls overall surgical procedure by manipulating the self-powered, computer aided robot, that comprises of miniature surgical instruments mounted on its robotic arms. Surgical robots are commonly used in minimally invasive surgery, remote surgery, and unmanned surgery. The increasing commercialization of surgical robots consequently propagates the growth of global surgical robotics market. Access Full Description of this report at:- https://www.nextmsc.com/report/surgical-robotics-market Top Companies: Medtronic plc, Smith & Nephew Plc. (Blue Belt Technologies, Inc...
Read more

Beta-Lactam and Beta-lactamase Inhibitor Market Size, Growth, Trends and Demand 2020 to 2030

Image
The Global Beta-Lactam and Beta-lactamase Inhibitor Market was valued at USD 27.49 billion in 2019 and is predicted to reach USD 34.20 billion by 2030 with a CAGR of 1.9% during the forecast period. Beta-lactam inhibitors are a class of antibiotic agents that have a beta lactam ring in their molecular structure. These antibiotic agents help fight against bacterial infections and protozoa infections by killing the bacteria directly or stopping it from growing. Some examples of Beta lactam inhibitors are penicillin, carbapenem etc. Beta-lactamase inhibitors are a class of drugs that block the activity of the Beta-lactam enzymes and restricts the degradation of Beta-lactam. Access Full Description of this report at:- https://www.nextmsc.com/report/beta-lactam-beta-lactamase-inhibitors-market Top Companies: Abbott Laboratories, Allergan plc. F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc., Merck & Co. Inc. Mylan N.V., Novartis International AG, Pfizer Inc., Sanofi and others...
Read more